To investigate the relationship of tissue oxygenation of different organs and tissue beds (e.g., a tissue bed on the arm vs. leg vs. flank tissue bed(s) and renal tissue bed, and thus can be used as a surrogate of renal tissue oxygenation monitoring.
In this study, we will monitor tissue oxygenation of four different tissue beds including cerebral tissue (SctO2) on the forehead, and 3 somatic tissue beds monitored on the forearm (SarmO2), upper leg (SlegO2), and the renal region (SrrO2). The primary end point is AKI and the secondary end points are postoperative major non-renal complications (e.g. stroke, delirium, myocardial infraction, heart failure, new or worsening arrhythmia, mechanical ventilation \> 24 hours, deep wound infection, etc.) and mortality. The associations between tissue oxygenation of different tissue beds, i.e. SctO2, SarmO2, SlegO2, and SrrO2, and AKI and non-renal outcomes will be compared to explore the tissue bed(s) whose oxygen saturation has a stronger association with the outcomes of interest. The strength of this study is to use the patient as self-control.
Study Type
OBSERVATIONAL
Enrollment
110
Tissue oxygenation was monitored using a tissue oximeter based on near-infrared spectroscopy (FORE-SIGHT Elite, CASMED, Inc., Branford, Connecticut, USA). The oximeter had four cables with each cable connected to an adhesive probe.
Xijing Hospital
Xi'an, Shaanxi, China
Postoperative acute kidney injury (AKI)
AKI is defined as any of the following (Not Graded): * K Increase in serum creatinine (SCr) by X0.3 mg/dl (X26.5 lmol/l) within 48 hours; or * K Increase in SCr to X1.5 times baseline, which is known or presumed to have occurred within the prior 7 days; or * K Urine volume o0.5 ml/kg/h for 6 hours.AKI is defined as any of the following (Not Graded): * K Increase in SCr by X0.3 mg/dl (X26.5 lmol/l) within 48 hours; or * K Increase in SCr to X1.5 times baseline, which is known or presumed to have occurred within the prior 7 days; or * K Urine volume o0.5 ml/kg/h for 6 hours. AKI is defined as any of the following (Not graded):Increase in SCr by X0.3 mg/dl (X26.5 lmol/l) within 48 hours; or increase in SCr to X1.5 times baseline, which is known or presumed to have occurred within the prior 7 days; or urine volume less than 0.5 ml/kg/h for 6 hours.
Time frame: Seven days postoperatively
Length of mechanical ventilation
Time between intubation and extubation
Time frame: Postoperative day 0-day 7
Length of ICU stay
Days between end of operation and departure of ICU
Time frame: Postoperative day 0-day 7
Length of hospital stay
Days between end of operation and hospital discharge
Time frame: Postoperative day 0-day 30
Adverse events in 30 days
Clinical events since hospital discharge
Time frame: Postoperative day 0-day 30
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.